HBCP bears build ahead of earnings, options traders push the other way

Call buyers are flooding into HBCP hours before Home Bancorp reports earnings on 20 October. The put-call ratio has dropped to 1.19, down 3.6 standard deviations from its 20-day mean of 1.46. That is the most aggressive call-skew the stock has seen in recent weeks. At the same time, short sellers have been adding positions at the fastest pace in months. The two camps are pulling in opposite directions, and one side will be wrong by tomorrow.

Options traders turn bullish

The PCR collapse tells a clear story. A ratio above 1.0 usually signals net put bias. HBCP's ratio sat near 1.49 for most of September. The drop to 1.19 on 16 October means call buying has accelerated sharply into the print. The 52-week low for the PCR stands at 0.33, so the move is not yet extreme on an absolute basis, but a 3.6 standard deviation swing in a matter of days is unusual for a small community bank with thin options volume.

Short sellers disagree

Short interest rose 42% in one week to 3.4% of free float, as of 16 October. That is the sharpest weekly build in recent history. Cost to borrow climbed 113% over the same period to 0.51%, though at that level it remains low in absolute terms. Availability stands at 5,193%, meaning roughly 2.5 million shares sit in the lending pool against the current short position. There is no shortage of stock to borrow. Bears are choosing to press the position, not being forced into it by a tight lending market.

The ORTEX short score rose from 32.6 on 8 October to 36.6 on 16 October, a meaningful step up in a short time, driven by the surge in estimated short shares.

What the bank's own data shows

FDIC call report data from the Federal Deposit Insurance Corporation shows total deposits at Home Bancorp have risen for eight consecutive quarters, reaching $3.08 billion as of the end of Q2 2026. Net loans and leases hit a record for any Q2 since 2024 at $2.75 billion. These are backwards-looking figures, but they describe a balance sheet that has been growing steadily heading into this print.

The bull case from analysts rests on loan growth re-accelerating toward 4 to 6% annually as rate conditions ease. Piper Sandler downgraded the stock to Neutral in April 2026, citing no specific target at the time. Raymond James keeps an Outperform rating with a $62 target, last updated in July 2025. The consensus mean target sits at $73, against a last close of $65.90.

BlackRock added 78,322 shares in the quarter ending 30 September. State Street added 183,801. Both moves were disclosed as of 30 September and are the most notable recent institutional flows on record.

Data summary

• Short interest: 3.4% of free float, up 42% in one week
• Cost to borrow: 0.51%, up 113% in one week, level classified as low
• Availability: 5,193%, ample borrow supply
• PCR: 1.19, down 3.6 standard deviations from 20-day mean of 1.46
• ORTEX short score: 36.6, up from 32.6 on 8 October
• Earnings: scheduled 20 October 2026
• Consensus price target: $73.00, last close $65.90